GoodRx Holdings (GDRX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on GoodRx Holdings (GDRX) is Neutral.

The composite score behind that read is -0.06, weighing +0.09 of bullish evidence against -0.31 bearish.

GoodRx Holdings last closed at $3.43, +2.08% on the session.

Against the IVW growth benchmark the position is +1.28% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for GDRX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks GoodRx Holdings in the 8th percentile on valuation and the 44th percentile on return on equity, where 100 is best.

GoodRx Holdings is classified under Health Care / Health Care Technology, with a market capitalisation of $1.15B.

StockMap tracks GoodRx Holdings as the 7th largest of the 20 companies it covers in the Health Care Technology industry, part of the Health Care sector.

Across that group the current two-week reads are 14 Neutral, 5 Moderate Underperform and 1 Moderate Outperform.

On that composite GoodRx Holdings ranks 13th of 20 in the group, against a group median of +0.01.